Literature DB >> 23679168

Successful coil embolization for life-threatening hemorrhage in childhood leukemia induction therapy.

Jun Hayakawa1, Takahiro Ueda, Yusuke Fujiwara, Yusuke Ozaki, Satoshi Wakita, Miho Maeda, Yoshitaka Fukunaga.   

Abstract

An 11-year-old boy was experienced severe life-threatening hemorrhage from a branch of the superior mesenteric artery (SMA) after acute lymphoblastic leukemia induction therapy. The patient had a history of attention deficit hyperactivity disorder (ADHD), diagnosed at 3 years of age. Subsequent to discontinuing his psychotropic medication, the patient's mental status deteriorated and treatment with midazolam for 3 weeks was necessary to allow the completion of the leukemia induction regimen. On day 51, although there was no indication of thrombocytopenia or a coagulation disorder, the patient began to hemorrhage suddenly from anal with resulting hypovolemic shock, and large-volume blood transfusion was initiated. Although upper and lower endoscopy failed to determine the location of the hemorrhage, angiography enabled us to determine that it was a branch of the SMA (the middle colic artery #6), and selective arterial embolization was used to arrest the bleeding. There could have been underlying causes, such as, a probable malformation or aneurysm in that area, although there was no indication before or after the event. This is a rare case of arterial hemorrhage from a branch of the SMA that occurred in a pediatric patient idiopathically during the induction therapy of leukemia.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Mesh:

Year:  2013        PMID: 23679168     DOI: 10.1111/j.1442-200X.2012.03682.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  Superselective arterial embolization of the superior mesenteric artery for the treatment of gastrointestinal hemorrhage following allogeneic hematopoietic stem cell transplantation.

Authors:  Run-Zhe Chen; Gang Zhao; Nan Jin; Bao-An Chen; Jia-Hua Ding
Journal:  Patient Prefer Adherence       Date:  2014-11-13       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.